Goldman Sachs raises Rhythm Pharmaceuticals stock price target on HO launch outlook

Investing.comThursday, September 25, 2025 at 8:51:21 AM
Goldman Sachs raises Rhythm Pharmaceuticals stock price target on HO launch outlook
Goldman Sachs has raised its price target for Rhythm Pharmaceuticals, reflecting optimism about the company's upcoming HO launch. This adjustment signals confidence in Rhythm's potential to deliver innovative treatments, which could significantly impact the market and improve patient outcomes. Investors are likely to view this as a positive development, indicating a strong future for the company.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Goldman Sachs reshuffles EU bank ratings, backs UniCredit, Santander, Banco BPM
PositiveFinancial Markets
Goldman Sachs has made significant changes to its ratings of European banks, expressing strong support for UniCredit, Santander, and Banco BPM. This move is important as it reflects confidence in these institutions' stability and growth potential, which could influence investor sentiment and market dynamics in the European banking sector.
Xcel Energy stock rises as Goldman Sachs reiterates Buy rating
PositiveFinancial Markets
Xcel Energy's stock has seen a notable rise following Goldman Sachs' decision to reiterate its 'Buy' rating on the company. This endorsement from a major financial institution signals confidence in Xcel's future performance, which is encouraging for investors. The positive outlook could lead to increased interest in the stock, potentially boosting its value further.
Goldman’s Petershill Plans to Return Capital, Delist From LSE
NegativeFinancial Markets
Goldman Sachs-backed Petershill Partners is set to return capital to its investors and delist from the London Stock Exchange, highlighting ongoing struggles in the UK's capital markets and investment trust sector. This move is significant as it reflects broader challenges faced by the industry, raising concerns about investor confidence and the future of investment opportunities in the region.
Goldman Sachs downgrades copper supply forecast after Grasberg mine disruption
NegativeFinancial Markets
Goldman Sachs has downgraded its copper supply forecast following disruptions at the Grasberg mine, one of the world's largest copper producers. This downgrade is significant as it highlights potential challenges in meeting global copper demand, which is crucial for various industries, including electric vehicles and renewable energy. Investors and manufacturers alike should pay attention to these developments, as they could impact prices and availability in the near future.
Goldman Sachs initiates Edgewise Therapeutics stock with Neutral rating
NeutralFinancial Markets
Goldman Sachs has initiated coverage of Edgewise Therapeutics, assigning it a Neutral rating. This move is significant as it reflects the investment bank's cautious stance on the company's potential in the market. Investors will be watching closely to see how Edgewise navigates its growth strategy and responds to market conditions.
Goldman Has ‘Serious Doubts’ First Brands Will Avoid Bankruptcy
NegativeFinancial Markets
Goldman Sachs analysts have expressed significant concerns regarding the financial stability of First Brands Group, an auto-parts supplier, suggesting that bankruptcy may be imminent. This matters because it highlights the challenges faced by companies in the auto industry, especially in a volatile market, and could have ripple effects on suppliers and the broader economy.
Morgan Stanley raises Rhythm Pharmaceuticals stock price target on higher obesity market potential
PositiveFinancial Markets
Morgan Stanley has raised its price target for Rhythm Pharmaceuticals, reflecting a growing optimism about the potential of the obesity market. This adjustment signals confidence in the company's prospects and highlights the increasing recognition of obesity as a significant health issue. Investors may see this as a positive indicator of future growth and innovation in treatments.
Banks Launch $5.5 Billion Loan to Fund Dayforce’s Pending Buyout
PositiveFinancial Markets
A consortium of banks led by Goldman Sachs has initiated a substantial $5.5 billion leveraged loan to support Thoma Bravo's acquisition of Dayforce, a key player in human-resources software. This move not only highlights the confidence in Dayforce's potential but also underscores the growing interest in HR technology investments. Such financing can significantly enhance Dayforce's capabilities and market reach, making it a noteworthy development in the tech and finance sectors.
Goldman Sachs upgrades GXO Logistics stock to Buy on improved growth outlook
PositiveFinancial Markets
Goldman Sachs has upgraded GXO Logistics stock to a 'Buy' rating, citing an improved growth outlook for the company. This upgrade is significant as it reflects confidence in GXO's ability to navigate the logistics sector effectively, especially in a time when supply chain efficiency is crucial. Investors may see this as a positive signal for potential returns, making it a noteworthy development in the financial markets.
Tata Consumer Products price target raised to INR1,290 by Goldman Sachs
PositiveFinancial Markets
Goldman Sachs has raised its price target for Tata Consumer Products to INR 1,290, reflecting confidence in the company's growth potential. This adjustment is significant as it indicates strong market performance and investor interest, which could lead to increased stock value and attract more investors.
Zalando stock rating reiterated at Buy by Goldman Sachs
PositiveFinancial Markets
Goldman Sachs has reaffirmed its Buy rating for Zalando, signaling confidence in the company's growth potential. This endorsement is significant as it reflects the investment bank's belief in Zalando's ability to navigate the competitive online retail landscape successfully. Investors often look to such ratings as indicators of future performance, making this news particularly relevant for those interested in the stock market.
AutoZone stock falls as Goldman Sachs maintains Neutral rating
NegativeFinancial Markets
AutoZone's stock has taken a hit as Goldman Sachs has decided to maintain a Neutral rating on the company. This news is significant as it reflects the cautious outlook from a major financial institution, which could influence investor confidence and market performance. Investors often look to ratings from firms like Goldman Sachs to gauge the potential for growth or decline in stock value.
Latest from Financial Markets
Dollar May Be Culprit If Trends Derail: 3-Minutes MLIV
NeutralFinancial Markets
In today's episode of 'Bloomberg: The Opening Trade,' analysts Anna Edwards, Guy Johnson, Lizzy Burden, and Mark Cudmore discuss the potential impact of the dollar on market trends. This conversation is crucial for investors as it highlights how currency fluctuations can influence investment strategies and market dynamics.
Drones seen at 4 more Danish airports in ‘systematic’ attack
NegativeFinancial Markets
Drones have been spotted at four additional airports in Denmark, leading to a temporary shutdown of a military airfield for several hours. This incident highlights the growing concern in Europe regarding airspace violations, as authorities remain on high alert. The systematic nature of these attacks raises questions about security measures and the potential implications for air travel and military operations in the region.
Brookfield Business Partners to simplify structure with single entity
PositiveFinancial Markets
Brookfield Business Partners is taking a significant step to simplify its structure by consolidating into a single entity. This move is expected to enhance operational efficiency and streamline decision-making processes, which could lead to better performance and increased shareholder value. Such structural changes often reflect a company's commitment to adapting to market demands and improving its overall competitiveness.
Accenture posts fourth quarter revenue above estimates
PositiveFinancial Markets
Accenture has reported its fourth quarter revenue, surpassing analysts' expectations, which is a positive sign for the company's growth and stability. This strong performance highlights Accenture's ability to navigate market challenges and capitalize on opportunities, making it an important player in the consulting and technology sectors.
Accenture tops Q4 estimates, guides well above Wall Street for fiscal 2026
PositiveFinancial Markets
Accenture has exceeded expectations for its fourth-quarter earnings, providing a strong outlook for fiscal 2026 that surpasses Wall Street predictions. This positive performance highlights the company's robust growth strategy and resilience in a competitive market, making it a key player to watch in the consulting industry.
GE Vernova stock price target lowered to $658 from $668 at Jefferies
NegativeFinancial Markets
Jefferies has lowered its stock price target for GE Vernova from $668 to $658, indicating a less optimistic outlook for the company's future performance. This adjustment reflects concerns about market conditions and the company's ability to meet growth expectations. Investors should take note of this change as it may impact their investment strategies and perceptions of GE Vernova's potential.